Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares saw unusually-strong trading volume on Monday . Wolfe Research assumed coverage on shares of Oric Pharmaceuticals in a research report on Tuesday, November 18th. Piper Sandler began coverage on Oric Pharmaceuticals in a research report on Wednesday, January 7th. Oric Pharmaceuticals Company Profile(Get Free Report)Oric Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Featured StoriesReceive News & Ratings for Oric Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oric Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.